ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025
Green Synthesis of Copper Nanoparticles utilising the Maillard Reaction.
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Green Synthesis of Copper Nanoparticles utilising the Maillard Reaction.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A new approach for the fabrication copper nanoparticles by a wet chemical reduction method is reported. The natural resources arginine as amino compound and several monosaccharides (xylose, ribose, galactose and glucose) react characteristically performing an Amadori rearrangement followed by a Maillard type reaction. This reaction carried out in an aqueous solution ensures an environmentally friendly way of reducing copper(II) ions leading to the formation of the desired nanoparticles. By changing the concentration of the amino acid, simultaneously acting as a complexing agent, it is possible to tune the size of the resulting nano particles to a certain degree down to 3 nm. This nontoxic and facile preparation route with quantitative yield opens a wide field of applications ranging from electronics to medical approaches.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.